The paucity of research highlights the urgent need for further investigations of SIRT5’s function, as its modulation could present a novel therapeutic strategy by disrupting the metabolic dependencies that sustain pancreatic cancer cells. This evidence concerns the gene SIRT5 and pancreatic neoplasm.